{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:07:33Z","timestamp":1793286453410,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019956","name":"National NanoFab Center","doi-asserted-by":"publisher","award":["1711160154"],"award-info":[{"award-number":["1711160154"]}],"id":[{"id":"10.13039\/501100019956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020M3A9E4104385"],"award-info":[{"award-number":["NRF-2020M3A9E4104385"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF- 2022R1F1A1074346"],"award-info":[{"award-number":["NRF- 2022R1F1A1074346"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.lfs.2023.121802","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T13:12:32Z","timestamp":1685020352000},"page":"121802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Recent advances in using folate receptor 1 (FOLR1) for cancer diagnosis and treatment, with an emphasis on cancers that affect women"],"prefix":"10.1016","volume":"326","author":[{"given":"Pavitra","family":"Varaganti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanath","family":"Buddolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buddolla Anantha","family":"Lakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10071","key":"10.1016\/j.lfs.2023.121802_bb0005","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(16)31795-0","article-title":"Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries","volume":"389","author":"Denny","year":"2017","journal-title":"Lancet"},{"issue":"3\u20134","key":"10.1016\/j.lfs.2023.121802_bb0010","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.jcpo.2013.07.002","article-title":"Breast and cervical cancer control in low and middle-income countries: human rights meet sound health policy","volume":"1","author":"Ginsburg","year":"2013","journal-title":"J. Cancer Policy"},{"issue":"10071","key":"10.1016\/j.lfs.2023.121802_bb0015","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(16)31392-7","article-title":"The global burden of women\u2019s cancers: a grand challenge in global health","volume":"389","author":"Ginsburg","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.lfs.2023.121802_bb0020","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/17425247.2012.694863","article-title":"Clinical translation of folate receptor-targeted therapeutics","volume":"9","author":"Teng","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"issue":"10","key":"10.1016\/j.lfs.2023.121802_bb0025","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2967\/jnumed.120.255760","article-title":"Identification of a PET radiotracer for imaging of the folate receptor-\u03b1: a potential tool to select patients for targeted tumor therapy","volume":"62","author":"Guzik","year":"2021","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41392-020-0115-0","article-title":"Targeting folate receptor \u03b2 positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex","volume":"5","author":"Tie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2022.100917","article-title":"Folate receptor as a biomarker and therapeutic target in solid tumors","volume":"47","author":"Young","year":"2023","journal-title":"Curr. Probl. Cancer"},{"issue":"8","key":"10.1016\/j.lfs.2023.121802_bb0040","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/ijc.29937","article-title":"Serum folate receptor alpha as a biomarker for ovarian cancer: implications for diagnosis, prognosis and predicting its local tumor expression","volume":"138","author":"Kurosaki","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2023.121802_bb0045","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s13346-018-0589-2","article-title":"The folate receptor \u03b2 as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis","volume":"9","author":"Chandrupatla","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170389","article-title":"Folate transporters in placentas from preterm newborns and their relation to cord blood folate and vitamin B12 levels","volume":"12","author":"Casta\u00f1o","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2023.121802_bb0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-12-800223-0.00004-9","article-title":"Biology of the major facilitative folate transporters SLC19A1 and SLC46A1","volume":"73","author":"Hou","year":"2014","journal-title":"Curr. Top. Membr."},{"issue":"4","key":"10.1016\/j.lfs.2023.121802_bb0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jimd.12092","article-title":"Cerebral folate deficiency: analytical tests and differential diagnosis","volume":"42","author":"Pope","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"20","key":"10.1016\/j.lfs.2023.121802_bb0065","doi-asserted-by":"crossref","first-page":"E4095","DOI":"10.1073\/pnas.1619582114","article-title":"Folate rescues vitamin B12 depletion-induced inhibition of nuclear thymidylate biosynthesis and genome instability","volume":"114","author":"Palmer","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12987-022-00391-3","article-title":"Novel localization of folate transport systems in the murine central nervous system","volume":"19","author":"Sangha","year":"2022","journal-title":"Fluids Barriers CNS."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.121802_bb0075","first-page":"46","article-title":"Environmental and nutritional effects on the epigenetic regulation of genes","volume":"600","author":"Feil","year":"2006","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191333","article-title":"Menstrual and reproductive factors and risk of breast cancer: a case-control study in the Fez region, Morocco","volume":"13","author":"Khalis","year":"2018","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.lfs.2023.121802_bb0085","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.3390\/molecules26123731","article-title":"The concept of folic acid in health and disease","volume":"26","author":"Shulpekova","year":"2021","journal-title":"Molecules."},{"issue":"4\u20136","key":"10.1016\/j.lfs.2023.121802_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drup.2014.10.002","article-title":"The folate receptor as a rational therapeutic target for personalized cancer treatment","volume":"17","author":"Assaraf","year":"2014","journal-title":"Drug Resist. Updat."},{"issue":"8","key":"10.1016\/j.lfs.2023.121802_bb0095","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.addr.2004.01.003","article-title":"Antifolates targeted specifically to the folate receptor","volume":"56","author":"Jackman","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0100","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.1038\/s41598-018-26683-z","article-title":"Identification of a peptide for folate receptor alpha by phage display and its tumor targeting activity in ovary cancer xenograft","volume":"8","author":"Xing","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.121802_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/709049","article-title":"Early detection biomarkers for ovarian cancer","volume":"2012","author":"Sarojini","year":"2012","journal-title":"J. Oncol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121802_bb0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41571-020-0339-5","article-title":"Exploiting the folate receptor \u03b1 in oncology","volume":"17","author":"Scaranti","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.lfs.2023.121802_bb0115","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/sj.gt.3301962","article-title":"Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies","volume":"10","author":"Figini","year":"2003","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-018-0387-y","article-title":"FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells","volume":"11","author":"Huang","year":"2018","journal-title":"J. Ovarian Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.121802_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122209","article-title":"Folate receptor-\u03b1 (FOLR1) expression and function in triple negative tumors","volume":"10","author":"Necela","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.lfs.2023.121802_bb0130","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/bjc.2014.567","article-title":"Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An ovarian tumour tissue analysis consortium study","volume":"111","author":"K\u00f6bel","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2023.121802_bb0135","first-page":"597","article-title":"Genes involved with folate uptake and distribution and their association with colorectal cancer risk","volume":"21","author":"Figueiredo","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"10","key":"10.1016\/j.lfs.2023.121802_bb0140","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/annonc\/mdv250","article-title":"Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments","volume":"26","author":"Ledermann","year":"2015","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.lfs.2023.121802_bb0145","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cellsig.2015.03.020","article-title":"Folic acid mediates activation of the pro-oncogene STAT3 via the folate receptor alpha","volume":"27","author":"Hansen","year":"2015","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1515\/pteridines-2020-0006","article-title":"Bioinformatics analysis of FOLR1 expression, functional enrichment, related signaling pathways and relationship with prognosis in ovarian cancer","volume":"31","author":"Wang","year":"2020","journal-title":"Pteridines."},{"issue":"32","key":"10.1016\/j.lfs.2023.121802_bb0155","doi-asserted-by":"crossref","first-page":"52553","DOI":"10.18632\/oncotarget.9651","article-title":"Targeting folate receptor alpha for cancer treatment","volume":"7","author":"Cheung","year":"2016","journal-title":"Oncotarget."},{"issue":"12","key":"10.1016\/j.lfs.2023.121802_bb0160","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.18632\/oncotarget.412","article-title":"Characterization of the human folate receptor alpha via novel antibody-based probes","volume":"2","author":"O\u2019Shannessy","year":"2011","journal-title":"Oncotarget."},{"issue":"5","key":"10.1016\/j.lfs.2023.121802_bb0165","first-page":"700","article-title":"Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results","volume":"44","author":"Siegel","year":"2003","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/cr068212n","article-title":"Dendrimers in oncology: an expanding horizon","volume":"109","author":"Tekade","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.lfs.2023.121802_bb0175","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3389\/fonc.2019.01537","article-title":"Ovarian cancer targeted theranostics","volume":"9","author":"Nimmagadda","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2023.121802_bb0180","doi-asserted-by":"crossref","unstructured":"Zhao X, Li H, Lee RJ. Targeted drug delivery via folate receptors. Expert Opin. Drug Deliv.. 5(3):309\u201319. doi:https:\/\/doi.org\/10.1517\/17425247.5.3.309.","DOI":"10.1517\/17425247.5.3.309"},{"issue":"5","key":"10.1016\/j.lfs.2023.121802_bb0185","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41551-022-00891-5","article-title":"Multiplexed imaging in oncology","volume":"6","author":"Andreou","year":"2022","journal-title":"Nat. Biomed. Eng."},{"issue":"8","key":"10.1016\/j.lfs.2023.121802_bb0190","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.addr.2004.01.009","article-title":"Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential","volume":"56","author":"Lu","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.lfs.2023.121802_bb0195","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/bc0200430","article-title":"Synthesis and biological evaluation of EC20: a new folate-derived, 99mTc-based radiopharmaceutical","volume":"13","author":"Leamon","year":"2002","journal-title":"Bioconjug. Chem."},{"issue":"10","key":"10.1016\/j.lfs.2023.121802_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013300","article-title":"Cerenkov radiation energy transfer (CRET) imaging: a novel method for optical imaging of PET isotopes in biological systems","volume":"5","author":"Dothager","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.lfs.2023.121802_bb0205","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/art.10405","article-title":"Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis","volume":"46","author":"Turk","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0210","first-page":"118","article-title":"Targeting the folate receptor for the treatment of ovarian cancer","volume":"4","author":"Lutz","year":"2015","journal-title":"Transl. Cancer Res."},{"issue":"10","key":"10.1016\/j.lfs.2023.121802_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2020.140466","article-title":"Characterization of soluble folate receptors (folate binding proteins) in humans. Biological roles and clinical potentials in infection and malignancy","volume":"1868","author":"Holm","year":"2020","journal-title":"Biochim. Biophys. Acta Protein Proteomics"},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41571-021-00548-3","article-title":"Fundamentals and developments in fluorescence-guided cancer surgery","volume":"19","author":"Mieog","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.lfs.2023.121802_bb0225","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41571-020-0339-5","article-title":"Exploiting the folate receptor \u03b1 in oncology","volume":"17","author":"Scaranti","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"64","key":"10.1016\/j.lfs.2023.121802_bb0230","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.22376","article-title":"Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy","volume":"8","author":"Thulasidasan","year":"2017","journal-title":"Oncotarget."},{"issue":"8","key":"10.1016\/j.lfs.2023.121802_bb0235","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.addr.2004.01.005","article-title":"Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor","volume":"56","author":"Zhao","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.lfs.2023.121802_bb0240","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.addr.2004.01.011","article-title":"Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid\u2013PEG conjugates","volume":"56","author":"Gabizon","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"22","key":"10.1016\/j.lfs.2023.121802_bb0245","first-page":"6125","article-title":"Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein","volume":"51","author":"Coney","year":"1991","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2023.121802_bb0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0168-3659(03)00215-3","article-title":"Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects","volume":"91","author":"Lu","year":"2003","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.lfs.2023.121802_bb0255","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ijc.22811","article-title":"Folate receptor overexpression is associated with poor outcome in breast cancer","volume":"121","author":"Hartmann","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.lfs.2023.121802_bb0260","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1021\/acs.molpharmaceut.9b00653","article-title":"Folate receptor \u03b1-targeted 89Zr-M9346A immuno-PET for image-guided intervention with mirvetuximab soravtansine in triple-negative breast cancer","volume":"16","author":"Heo","year":"2019","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0265","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/antib10010006","article-title":"Novel anti-FOLR1 antibody\u2013drug conjugate MORAb-202 in breast cancer and non-small cell lung cancer cells","volume":"10","author":"Matsunaga","year":"2021","journal-title":"Antibodies."},{"issue":"7","key":"10.1016\/j.lfs.2023.121802_bb0270","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1021\/acsanm.2c01502","article-title":"DNA-functionalized gold nanorods for perioperative optical imaging and photothermal therapy of triple-negative breast cancer","volume":"5","author":"Pal","year":"2022","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.lfs.2023.121802_bb0275","first-page":"9","article-title":"Folate-functionalized DNA origami for targeted delivery of doxorubicin to triple-negative breast cancer","author":"Pal","year":"2021","journal-title":"Front. Chem."},{"issue":"18","key":"10.1016\/j.lfs.2023.121802_bb0280","doi-asserted-by":"crossref","first-page":"2009733","DOI":"10.1002\/adfm.202009733","article-title":"Tumor acidity and near-infrared light responsive dual drug delivery polydopamine-based nanoparticles for chemo-photothermal therapy","volume":"31","author":"Fan","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"3","key":"10.1016\/j.lfs.2023.121802_bb0285","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.apsb.2021.09.024","article-title":"Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: dual targeting of tumor cells and tumor-associated macrophages","volume":"12","author":"Moharil","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2023.121802_bb0290","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.2147\/IJN.S244712","article-title":"Folate and pegylated aliphatic polyester nanoparticles for targeted anticancer drug delivery","volume":"15","author":"Tsolou","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"20","key":"10.1016\/j.lfs.2023.121802_bb0295","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.lfs.2023.121802_bb0300","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.neo.2016.11.002","article-title":"Mirvetuximab soravtansine (IMGN853), a folate receptor alpha\u2013targeting antibody-drug conjugate, potentiates the activity of standard of care therapeutics in ovarian cancer models","volume":"18","author":"Ponte","year":"2016","journal-title":"Neoplasia."},{"key":"10.1016\/j.lfs.2023.121802_bb0305","first-page":"2635","article-title":"Near-infrared fluorescent agent for in vitro screening of endometrial cancer and precancerous lesions","volume":"11","author":"Liang","year":"2021","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.lfs.2023.121802_bb0310","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1002\/cam4.2378","article-title":"Final analysis of a phase I\/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients","volume":"8","author":"Brown","year":"2019","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0315","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ygyno.2007.05.018","article-title":"Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas","volume":"107","author":"Allard","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.lfs.2023.121802_bb0320","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbrc.2017.08.015","article-title":"Folate receptor alpha is associated with cervical carcinogenesis and regulates cervical cancer cells growth by activating ERK1\/2\/c-Fos\/c-Jun","volume":"491","author":"Liu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0325","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1515\/pteridines-2020-0014","article-title":"FOLR1 was up-regulated in cervical squamous cell carcinoma and correlated with the patients\u2019 progression free survival","volume":"31","author":"Xie","year":"2020","journal-title":"Pteridines."},{"key":"10.1016\/j.lfs.2023.121802_bb0330","doi-asserted-by":"crossref","unstructured":"Liang Z, Dong J, Yang N, Li SD, Yang ZY, Huang R, Li FJ, Wang WT, Ren JK, Lei J, Xu C. Tandem CAR-T cells targeting FOLR1 and MSLN enhance the antitumor effects in ovarian cancer. Int. J. Biol. Sci.. 17(15): 4365. doi:https:\/\/doi.org\/10.7150\/ijbs.63181.","DOI":"10.7150\/ijbs.63181"},{"issue":"64","key":"10.1016\/j.lfs.2023.121802_bb0335","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.22376","article-title":"Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy","volume":"8","author":"Thulasidasan","year":"2017","journal-title":"Oncotarget."},{"issue":"14","key":"10.1016\/j.lfs.2023.121802_bb0340","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.7314\/APJCP.2014.15.14.5667","article-title":"Down-regulation of FR\u03b1 inhibits proliferation and promotes apoptosis of cervical cancer cells in vitro","volume":"15","author":"Bai","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"4","key":"10.1016\/j.lfs.2023.121802_bb0345","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/annonc\/mdu024","article-title":"Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide)","volume":"25","author":"Morris","year":"2014","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.lfs.2023.121802_bb0350","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1158\/1538-7445.AM2011-1760","article-title":"Preclinical evaluation of IMGN853, an anti-FOLR1 antibody-maytansinoid conjugate, as a potential therapeutic for ovarian cancer","volume":"71","author":"Whiteman","year":"2011","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-018-0387-y","article-title":"FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells","volume":"11","author":"Huang","year":"2018","journal-title":"J. Ovarian Res."},{"issue":"9","key":"10.1016\/j.lfs.2023.121802_bb0360","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1021\/acs.molpharmaceut.9b00653","article-title":"Folate receptor \u03b1-targeted 89Zr-M9346A immuno-PET for image-guided intervention with mirvetuximab soravtansine in triple-negative breast cancer","volume":"16","author":"Heo","year":"2019","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.lfs.2023.121802_bb0365","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/cam4.1944","article-title":"Serum folate receptor \u03b1 (sFR) in ovarian cancer diagnosis and surveillance","volume":"8","author":"Farran","year":"2019","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.lfs.2023.121802_bb0370","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3390\/jcm9041185","article-title":"Photodynamic therapy using a new folate receptor-targeted photosensitizer on peritoneal ovarian cancer cells induces the release of extracellular vesicles with immunoactivating properties","volume":"9","author":"Baydoun","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0375","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2013.03.032","article-title":"Enhanced uptake and cytotoxity of folate-conjugated mitoxantrone-loaded micelles via receptor up-regulation by dexamethasone","volume":"448","author":"Chen","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0380","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10555-014-9539-8","article-title":"Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications","volume":"34","author":"Vergote","year":"2015","journal-title":"Cancer Metastasis Rev."},{"issue":"3","key":"10.1016\/j.lfs.2023.121802_bb0385","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tem.2021.12.003","article-title":"Emerging roles for folate receptor FOLR1 in signaling and cancer","volume":"33","author":"Nawaz","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.lfs.2023.121802_bb0390","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2967\/jnumed.113.133074","article-title":"Imaging the folate receptor on cancer cells with 99mTc-etarfolatide: properties, clinical use, and future potential of folate receptor imaging","volume":"55","author":"Maurer","year":"2014","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0395","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10555-014-9539-8","article-title":"Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications","volume":"34","author":"Vergote","year":"2015","journal-title":"Cancer Metastasis Rev."},{"issue":"8","key":"10.1016\/j.lfs.2023.121802_bb0400","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/jcp.56.8.569","article-title":"Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer","volume":"56","author":"Pillai","year":"2003","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0405","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2741\/1815","article-title":"Role of folate receptor genes in reproduction and related cancers","volume":"11","author":"Elnakat","year":"2006","journal-title":"Front. Biosci. Landmark."},{"issue":"2","key":"10.1016\/j.lfs.2023.121802_bb0410","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41416-022-02031-x","article-title":"Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes","volume":"128","author":"Bax","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2023.121802_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122209","article-title":"Folate receptor-\u03b1 (FOLR1) expression and function in triple negative tumors","volume":"10","author":"Necela","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.lfs.2023.121802_bb0420","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.addr.2004.01.001","article-title":"Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy","volume":"56","author":"Elnakat","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"16","key":"10.1016\/j.lfs.2023.121802_bb0425","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1021\/bi00016a042","article-title":"Folate receptor type. Gamma. Is primarily a secretory protein due to lack of an efficient signal for glycosylphosphatidylinositol modification: protein characterization and cell type specificity","volume":"34","author":"Shen","year":"1995","journal-title":"Biochemistry."},{"issue":"10","key":"10.1016\/j.lfs.2023.121802_bb0430","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/annonc\/mdv250","article-title":"Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments","volume":"26","author":"Ledermann","year":"2015","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0435","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10555-007-9048-0","article-title":"The folate receptor: what does it promise in tissue-targeted therapeutics?","volume":"26","author":"Salazar","year":"2007","journal-title":"Cancer Metastasis Rev."},{"issue":"7497","key":"10.1016\/j.lfs.2023.121802_bb0440","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature13203","article-title":"Juno is the egg Izumo receptor and is essential for mammalian fertilization","volume":"508","author":"Bianchi","year":"2014","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.lfs.2023.121802_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-13-30","article-title":"A novel splice variant of folate receptor 4 predominantly expressed in regulatory T cells","volume":"13","author":"Tian","year":"2012","journal-title":"BMC Immunol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523004368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523004368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:45:19Z","timestamp":1778647519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523004368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":89,"alternative-id":["S0024320523004368"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121802","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in using folate receptor 1 (FOLR1) for cancer diagnosis and treatment, with an emphasis on cancers that affect women","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.121802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121802"}}